BioCardia Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. BioCardia prevailing Real Value cannot be determined due to lack of data. The current price of BioCardia is $0.0. Our model approximates the value of BioCardia from analyzing the firm fundamentals such as Revenue of 477 K, return on equity of -7.04, and Operating Margin of (41.36) % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that BioCardia's price fluctuation is out of control at this time. Calculation of the real value of BioCardia is based on 3 months time horizon. Increasing BioCardia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioCardia stock is determined by what a typical buyer is willing to pay for full or partial control of BioCardia. Since BioCardia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioCardia Stock. However, BioCardia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 | Naive 0.002341 |
The intrinsic value of BioCardia's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioCardia's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioCardia helps investors to forecast how BioCardia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioCardia more accurately as focusing exclusively on BioCardia's fundamentals will not take into account other important factors: BioCardia Total Value Analysis
BioCardia is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of 1.31 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioCardia fundamentals before making investing decisions based on enterprise value of the companyBioCardia Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioCardia has an asset utilization ratio of 15.97 percent. This indicates that the Company is making $0.16 for each dollar of assets. An increasing asset utilization means that BioCardia is more efficient with each dollar of assets it utilizes for everyday operations.BioCardia Profitability Analysis
The company reported the revenue of 477 K. Net Loss for the year was (11.57 M) with profit before overhead, payroll, taxes, and interest of 0.About BioCardia Valuation
Our relative valuation model uses a comparative analysis of BioCardia. We calculate exposure to BioCardia's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioCardia's related companies.BioCardia Growth Indicators
Investing in growth stocks can be very risky. If the company such as BioCardia does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 21.2 M | |
| Shares Float | 1.2 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |